Personalis Inc. (PSNL) NASDAQ

$1.52 0.07 (4.48%)

Market Cap: $73.23M

As of 03/28/24 12:16 PM EDT. Market open.

(PSNL)

Personalis Inc. (PSNL)
NASDAQ

$1.52
0.07 (4.48%)

Market Cap: $73.23M

As of 03/28/24 12:16 PM EDT. Market open.

Add to Portfolio

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing ... read more

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer. read less

COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
Medical Laboratories
CEO
John West
Full Time Employees
428
URL
Address
1330 Obrien Dr, California, Menlo Park, 94025-1436.
Sector
Health Care and Social Assistance
Industry
Medical Laboratories
CEO
John West
Full Time Employees
428
Address
1330 Obrien Dr, California, Menlo Park, 94025-1436.
PRICE CHART FOR PERSONALIS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.49
Previous Close
$1.45
Days Range
$1.41 - $1.46
52 week range
$0.89 - $3.27
Volume
150,201
Avg. Volume (30 days)
410,876
Market Cap
$73.23M
Dividend Yield
-
P/E
(0.68)
Shares Outstanding
50,503,889
Open
$1.49
Previous Close
$1.45
Days Range
$1.41 - $1.46
52 week range
$0.89 - $3.27
Volume
150,201
Avg. Volume (30 days)
410,876
Market Cap
$73.23M
Dividend Yield
-
P/E
(0.68)
Shares Outstanding
50,503,889
FINANCIAL STATEMENTS FOR PERSONALIS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PERSONALIS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MYERS WOODROW A JRDirectorMar 01, 2024 Buy$1.6710,00016,70026,116Mar 05, 2024, 05:15 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPJan 29, 2024 Sale$1.37526721128,870Jan 31, 2024, 04:30 PM
Tachibana AaronCFO AND COOJan 29, 2024 Sale$1.37716981184,521Jan 31, 2024, 04:27 PM
Chen RichardChief Medical Officer and EVPDec 15, 2023 Sale$1.474,7086,921129,396Dec 19, 2023, 06:09 PM
Tachibana AaronCFO and COODec 15, 2023 Sale$1.476,7479,918185,237Dec 19, 2023, 06:07 PM
Moore Stephen MichaelGeneral CounselDec 15, 2023 Sale$1.471,4762,17076,920Dec 19, 2023, 06:02 PM
Moore Stephen MichaelGeneral CounselNov 16, 2023 Sale$1.041,7221,79178,396Nov 20, 2023, 04:30 PM
Tachibana AaronCFO and COONov 16, 2023 Sale$1.041,3441,398191,984Nov 20, 2023, 04:30 PM
Chen RichardChief Medical Officer and EVPNov 16, 2023 Sale$1.04940978124,104Nov 20, 2023, 04:30 PM
Hall Christopher MPresident and CEONov 01, 2023 Sale$0.9320,45919,027204,541Nov 03, 2023, 09:00 PM
Tachibana AaronCFO and COOJul 31, 2023 Sale$2.266621,496193,328Aug 02, 2023, 04:21 PM
Chen RichardChief Medical Officer and EVPJul 31, 2023 Sale$2.264851,096125,044Aug 02, 2023, 04:20 PM
Moore Stephen MichaelGeneral CounselJun 16, 2023 Sale$2.071,5093,12480,118Jun 21, 2023, 04:52 PM
Chen RichardChief Medical Officer and EVPJun 16, 2023 Sale$2.074,8179,971125,529Jun 21, 2023, 04:51 PM
Tachibana AaronCFO and COOJun 16, 2023 Sale$2.076,90414,291193,990Jun 21, 2023, 04:49 PM
Tachibana AaronCFO and COOMay 17, 2023 Sale$1.981,3892,750200,894May 19, 2023, 05:42 PM
Moore Stephen MichaelGeneral CounselMay 17, 2023 Sale$1.981,7813,52681,627May 19, 2023, 05:39 PM
Chen RichardChief Medical Officer and EVPMay 17, 2023 Sale$1.989711,923130,346May 19, 2023, 05:37 PM
Moore Stephen MichaelGeneral CounselMay 02, 2023 Sale$2.295,10211,68483,408May 04, 2023, 04:17 PM
Tachibana AaronCFO and COOMar 17, 2023 Sale$2.833,94511,164202,283Mar 21, 2023, 06:00 PM
Chen RichardChief Medical Officer and EVPMar 17, 2023 Sale$2.831,3143,719131,317Mar 21, 2023, 05:57 PM
Tachibana AaronChief Financial OfficerJan 31, 2023 Sale$2.207671,687206,228Feb 02, 2023, 05:12 PM
Chen RichardChief Medical OfficerJan 31, 2023 Sale$2.205621,236132,631Feb 02, 2023, 05:09 PM
Tachibana AaronChief Financial OfficerDec 20, 2022 Sale$1.923,8437,379206,995Dec 22, 2022, 05:07 PM
Chen RichardChief Medical OfficerDec 20, 2022 Sale$1.921,7503,360133,193Dec 22, 2022, 05:03 PM
Moore Stephen MichaelGeneral CounselDec 15, 2022 Sale$2.501,9304,82588,510Dec 19, 2022, 04:32 PM
Tachibana AaronChief Financial OfficerDec 15, 2022 Sale$2.507,17717,943210,838Dec 19, 2022, 04:28 PM
Chen RichardChief Medical OfficerDec 15, 2022 Sale$2.507,17717,943134,943Dec 19, 2022, 04:23 PM
West John StephenPresident and CEODec 14, 2022 Option Exercise$2.4410,00024,400622,444Dec 14, 2022, 04:03 PM
Tachibana AaronChief Financial OfficerDec 02, 2022 Sale$2.604,36011,336218,015Dec 06, 2022, 04:54 PM
Chen RichardChief Medical OfficerDec 02, 2022 Sale$2.604401,144142,120Dec 06, 2022, 04:50 PM
Chen RichardChief Medical OfficerNov 16, 2022 Sale$2.711,2953,509142,560Nov 18, 2022, 05:02 PM
Moore Stephen MichaelGeneral CounselNov 16, 2022 Sale$2.712,0455,54290,440Nov 18, 2022, 04:48 PM
Tachibana AaronChief Financial OfficerNov 16, 2022 Sale$2.711,2943,507222,375Nov 18, 2022, 04:43 PM
Chen RichardChief Medical OfficerSep 20, 2022 Sale$3.481,5815,502143,855Sep 22, 2022, 04:13 PM
Tachibana AaronChief Financial OfficerSep 20, 2022 Sale$3.483,47412,090223,669Sep 22, 2022, 04:09 PM
Chen RichardChief Medical OfficerSep 02, 2022 Sale$3.334201,399145,436Sep 08, 2022, 04:18 PM
Tachibana AaronChief Financial OfficerSep 02, 2022 Sale$3.334,16813,879227,143Sep 08, 2022, 04:09 PM
Chen RichardChief Medical OfficerJul 28, 2022 Sale$3.916322,471145,856Aug 01, 2022, 06:12 PM
Tachibana AaronChief Financial OfficerJul 28, 2022 Sale$3.916322,471231,311Aug 01, 2022, 06:05 PM
Chen RichardChief Medical OfficerJun 17, 2022 Sale$3.291,5655,149146,488Jun 21, 2022, 04:52 PM
Tachibana AaronChief Financial OfficerJun 17, 2022 Sale$3.293,44011,318231,943Jun 21, 2022, 04:48 PM
Moore Stephen MichaelGeneral CounselJun 15, 2022 Sale$3.241,8325,93673,885Jun 17, 2022, 05:11 PM
Chen RichardChief Medical OfficerJun 15, 2022 Sale$3.246,81822,090148,053Jun 17, 2022, 05:08 PM
Tachibana AaronChief Financial OfficerJun 15, 2022 Sale$3.246,81822,090235,383Jun 17, 2022, 05:02 PM
Tachibana AaronChief Financial OfficerJun 02, 2022 Sale$3.594,18715,031242,201Jun 06, 2022, 05:36 PM
Chen RichardChief Medical OfficerJun 02, 2022 Sale$3.594211,511154,871Jun 06, 2022, 05:30 PM
Tachibana AaronChief Financial OfficerMay 16, 2022 Sale$4.861,2866,250246,388May 18, 2022, 06:17 PM
West John StephenPresident and CEOMay 16, 2022 Sale$4.862,40811,703382,444May 18, 2022, 06:16 PM
Moore Stephen MichaelGeneral CounselMay 16, 2022 Sale$4.866643,22775,717May 18, 2022, 06:15 PM
Chen RichardChief Medical OfficerApr 29, 2022 Option Exercise$4.761,5587,416157,116May 18, 2022, 06:14 PM
Chen RichardChief Medical OfficerMay 16, 2022 Sale$4.861,2866,250155,830May 18, 2022, 06:14 PM
Moore Stephen MichaelGeneral CounselMay 02, 2022 Sale$5.535,73331,70376,381May 04, 2022, 05:38 PM
West John StephenPresident and CEOApr 20, 2022 Option Exercise$1.8445,06182,912384,852Apr 22, 2022, 05:25 PM
West John StephenPresident and CEOApr 13, 2022 Option Exercise$1.8464,430118,551404,221Apr 15, 2022, 06:24 PM
West John StephenPresident and CEOMar 17, 2022 Option Exercise$1.8454,34799,998339,804Mar 21, 2022, 08:44 PM
Tachibana AaronChief Financial OfficerMar 17, 2022 Option Exercise$7.983,76730,061247,674Mar 21, 2022, 08:42 PM
Chen RichardChief Medical OfficerMar 17, 2022 Option Exercise$7.981,77614,172155,558Mar 21, 2022, 08:41 PM
West John StephenPresident and CEOMar 15, 2022 Option Exercise$1.8468,162125,418353,619Mar 16, 2022, 08:40 PM
West John StephenPresident and CEOMar 14, 2022 Option Exercise$1.8421,20639,019306,663Mar 16, 2022, 08:40 PM
West John StephenPresident and CEOMar 15, 2022 Option Exercise$7.4768,162509,170285,457Mar 16, 2022, 08:40 PM
West John StephenPresident and CEOMar 14, 2022 Option Exercise$8.1521,206172,829285,457Mar 16, 2022, 08:40 PM
West John StephenPresident and CEOMar 11, 2022 Option Exercise$1.8410,88820,034296,339Mar 16, 2022, 08:39 PM
West John StephenPresident and CEOMar 10, 2022 Option Exercise$1.8432,89760,530318,354Mar 16, 2022, 08:39 PM
West John StephenPresident and CEOMar 11, 2022 Option Exercise$8.9910,88897,883285,457Mar 16, 2022, 08:39 PM
West John StephenPresident and CEOMar 10, 2022 Option Exercise$9.3832,897308,574285,457Mar 16, 2022, 08:39 PM
West John StephenPresident and CEOMar 11, 2022 Option Exercise$8.9910,88897,883241,672Mar 14, 2022, 05:56 PM
West John StephenPresident and CEOMar 10, 2022 Option Exercise$9.3832,897308,574252,560Mar 14, 2022, 05:56 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerMar 03, 2022 Buy$10.384,75049,3054,750Mar 04, 2022, 08:27 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerMar 03, 2022 Buy$9.83261,0112,565,7382,084,240Mar 04, 2022, 08:27 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerMar 02, 2022 Buy$9.9648,989487,9301,823,229Mar 04, 2022, 08:27 PM
Chen RichardChief Medical OfficerMar 02, 2022 Sale$10.184714,795157,334Mar 04, 2022, 06:09 PM
Tachibana AaronChief Financial OfficerMar 02, 2022 Sale$10.184,51145,922251,441Mar 04, 2022, 06:08 PM
Chen RichardChief Medical OfficerJan 28, 2022 Sale$9.937057,001157,805Feb 01, 2022, 06:05 PM
Tachibana AaronChief Financial OfficerJan 28, 2022 Sale$9.937057,001255,952Feb 01, 2022, 06:04 PM
West John StephenPresident and CEOJan 19, 2022 Sale$11.0164,503710,178285,457Jan 19, 2022, 07:22 PM
West John StephenPresident and CEOJan 18, 2022 Sale$11.7335,484416,227349,960Jan 19, 2022, 07:22 PM
Tachibana AaronChief Financial OfficerDec 17, 2021 Sale$12.803,43743,994256,657Dec 20, 2021, 07:59 PM
Chen RichardChief Medical OfficerDec 17, 2021 Sale$12.801,56320,006158,510Dec 20, 2021, 07:10 PM
West John StephenPresident and CEODec 17, 2021 Sale$12.802,73234,970385,444Dec 20, 2021, 07:00 PM
West John StephenPresident and CEODec 16, 2021 Sale$13.4297,2681,305,337388,176Dec 17, 2021, 09:17 PM
Chen RichardChief Medical OfficerDec 02, 2021 Sale$12.924195,41380,073Dec 06, 2021, 06:06 PM
Tachibana AaronChief Financial OfficerDec 02, 2021 Sale$12.924,18454,057180,094Dec 06, 2021, 06:05 PM
West John StephenPresident and CEONov 30, 2021 Sale$13.65100,0001,365,000485,444Dec 02, 2021, 05:49 PM
West John StephenPresident and CEONov 17, 2021 Sale$17.042,34840,010585,444Nov 19, 2021, 06:15 PM
Tachibana AaronChief Financial OfficerNov 17, 2021 Sale$17.041,25321,351184,278Nov 19, 2021, 06:14 PM
Chen RichardChief Medical OfficerOct 29, 2021 Option Exercise$16.6871111,85980,492Nov 19, 2021, 06:12 PM
Chen RichardChief Medical OfficerNov 17, 2021 Sale$17.041,25321,35179,781Nov 19, 2021, 06:12 PM
West John StephenPresident and CEOOct 12, 2021 Sale$19.33100,0001,933,000587,792Oct 14, 2021, 06:24 PM
Tachibana AaronChief Financial OfficerSep 17, 2021 Sale$21.253,15266,980185,531Sep 21, 2021, 06:36 PM
Chen RichardChief Scientific OfficerSep 17, 2021 Sale$21.251,08823,12081,034Sep 21, 2021, 06:35 PM
West John StephenPresident and CEOSep 14, 2021 Option Exercise$21.69100,0002,169,158694,392Sep 16, 2021, 06:28 PM
Tachibana AaronChief Financial OfficerSep 02, 2021 Sale$21.923,82083,734188,683Sep 07, 2021, 05:51 PM
Chen RichardChief Scientific OfficerSep 02, 2021 Sale$21.922916,37982,122Sep 07, 2021, 05:50 PM
West John StephenPresident and CEOAug 26, 2021 Option Exercise$0.4477,27234,000787,792Aug 30, 2021, 05:52 PM
West John StephenPresident and CEOAug 19, 2021 Option Exercise$0.44115,22850,700825,748Aug 23, 2021, 06:14 PM
West John StephenPresident and CEOAug 19, 2021 Option Exercise$16.81115,2281,936,983710,520Aug 23, 2021, 06:14 PM
Chen RichardChief Scientific OfficerAug 06, 2021 Option Exercise$21.1815,564329,64686,849Aug 10, 2021, 05:19 PM
Chen RichardChief Scientific OfficerAug 06, 2021 Sale$21.224,43694,13282,413Aug 10, 2021, 05:19 PM
West John StephenPresident and CEOJul 15, 2021 Option Exercise$0.4475,00033,000710,520Jul 20, 2021, 06:34 PM
West John StephenPresident and CEOJul 08, 2021 Option Exercise$0.44110,00048,400745,520Jul 12, 2021, 05:07 PM
West John StephenPresident and CEOJul 08, 2021 Sale$22.54110,0002,479,400635,520Jul 12, 2021, 05:07 PM
West John StephenPresident and CEOJun 08, 2021 Option Exercise$0.44110,00048,400670,520Jun 10, 2021, 05:17 PM
West John StephenPresident and CEOJun 08, 2021 Sale$22.43110,0002,467,272570,470Jun 10, 2021, 05:17 PM
Chen RichardChief Scientific OfficerJun 02, 2021 Sale$21.572916,27776,081Jun 04, 2021, 06:46 PM
Chen RichardChief Scientific OfficerMar 17, 2021 Sale$26.731,13030,20583,317Mar 19, 2021, 05:48 PM
Tachibana AaronChief Financial OfficerMar 17, 2021 Sale$26.732,44665,382167,823Mar 19, 2021, 05:47 PM
Tachibana AaronChief Financial OfficerMar 02, 2021 Sale$32.603,02298,517170,269Mar 04, 2021, 07:22 PM
Chen RichardChief Scientific OfficerMar 02, 2021 Sale$32.6034511,24784,447Mar 04, 2021, 07:21 PM
Chen RichardChief Scientific OfficerFeb 01, 2021 Option Exercise$0.4413,4225,90698,214Feb 03, 2021, 06:24 PM
Chen RichardChief Scientific OfficerFeb 01, 2021 Sale$38.6740,0001,546,993104,851Feb 03, 2021, 06:24 PM
Chen RichardChief Scientific OfficerDec 17, 2020 Sale$36.371,08739,534111,370Dec 21, 2020, 06:18 PM
Tachibana AaronChief Financial OfficerDec 17, 2020 Sale$36.372,39186,961173,291Dec 21, 2020, 06:18 PM
Chen RichardChief Scientific OfficerDec 01, 2020 Option Exercise$0.4440,00017,600152,750Dec 03, 2020, 07:23 PM
Chen RichardChief Scientific OfficerDec 02, 2020 Sale$27.762938,134112,457Dec 03, 2020, 07:23 PM
Chen RichardChief Scientific OfficerDec 01, 2020 Sale$28.0040,0001,119,989138,362Dec 03, 2020, 07:23 PM
Tachibana AaronChief Financial OfficerDec 02, 2020 Sale$27.762,92681,226175,682Dec 03, 2020, 07:21 PM
Abingworth LLPFormer 10% OwnerOct 20, 2020 Sale$27.66130,4863,609,2433,753,340Oct 21, 2020, 04:05 PM
Abingworth LLP10% OwnerOct 19, 2020 Sale$27.86196,4235,472,3453,883,826Oct 20, 2020, 04:06 PM
Abingworth LLP10% OwnerOct 16, 2020 Sale$26.6894,2182,513,7364,080,249Oct 20, 2020, 04:06 PM
Abingworth LLP10% OwnerOct 15, 2020 Sale$26.323,70097,3844,174,467Oct 16, 2020, 04:05 PM
Abingworth LLP10% OwnerOct 14, 2020 Sale$27.0881,9252,218,5294,178,167Oct 16, 2020, 04:05 PM
Abingworth LLP10% OwnerOct 12, 2020 Sale$29.09115,5413,361,0884,346,911Oct 14, 2020, 04:05 PM
Abingworth LLP10% OwnerOct 13, 2020 Sale$28.4386,8192,468,2644,260,092Oct 14, 2020, 04:05 PM
Chen RichardChief Scientific OfficerOct 01, 2020 Option Exercise$0.4437,45216,479152,750Oct 05, 2020, 07:00 PM
Chen RichardChief Scientific OfficerOct 01, 2020 Sale$22.0640,000882,452139,278Oct 05, 2020, 07:00 PM
Chen RichardChief Scientific OfficerSep 17, 2020 Sale$22.741,12025,469115,298Sep 21, 2020, 07:05 PM
Tachibana AaronChief Financial OfficerSep 17, 2020 Sale$22.742,46356,009178,608Sep 21, 2020, 07:03 PM
Tachibana AaronChief Financial OfficerSep 02, 2020 Sale$22.992,89966,648181,071Sep 04, 2020, 06:41 PM
Chen RichardChief Scientific OfficerSep 02, 2020 Sale$22.992916,690116,418Sep 04, 2020, 06:39 PM
Abingworth LLP10% OwnerAug 18, 2020 Sale$19.00986,84218,749,9984,462,452Aug 20, 2020, 04:00 PM
Chen RichardChief Scientific OfficerAug 14, 2020 Sale$20.1432,000644,392145,275Aug 18, 2020, 09:47 PM
LUDLUM KENDirectorAug 14, 2020 Sale$20.1720,000403,39436,470Aug 18, 2020, 09:35 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerAug 14, 2020 Buy$19.001,315,78924,999,9911,774,240Aug 18, 2020, 05:01 PM
Chen RichardChief Scientific OfficerJun 22, 2020 Sale$12.371,08513,421120,143Jun 24, 2020, 05:48 PM
Chen RichardChief Scientific OfficerJun 05, 2020 Sale$14.342723,900121,228Jun 11, 2020, 07:06 PM
Chen RichardChief Scientific OfficerJun 01, 2020 Sale$13.192893,812121,211Jun 03, 2020, 07:21 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerJun 02, 2020 Buy$13.98380,6545,321,543458,451Jun 03, 2020, 05:00 PM
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% OwnerJun 01, 2020 Buy$12.9877,7971,009,80577,797Jun 03, 2020, 05:00 PM
Chen RichardChief Scientific OfficerMar 09, 2020 Sale$7.841,0007,84059,000Mar 11, 2020, 05:37 PM
Chen RichardChief Scientific OfficerFeb 25, 2020 Sale$8.77101,000885,77059,000Mar 11, 2020, 05:34 PM
Chen RichardChief Scientific OfficerMar 02, 2020 Sale$8.761,0008,76059,000Mar 04, 2020, 06:05 PM
Chen RichardChief Scientific OfficerFeb 25, 2020 Sale$8.77101,000885,77059,000Feb 27, 2020, 09:40 PM
LUDLUM KENDirectorFeb 07, 2020 Option Exercise$3.804,16715,83550,000Feb 11, 2020, 06:44 PM
Chen RichardChief Scientific OfficerJan 07, 2020 Option Exercise$0.4412,0005,28059,000Jan 09, 2020, 07:57 PM
Chen RichardChief Scientific OfficerDec 20, 2019 Option Exercise$0.4412,0005,28047,000Dec 26, 2019, 06:54 PM
West John StephenPresident and CEONov 22, 2019 Option Exercise$8.653,00025,952505,412Nov 25, 2019, 06:40 PM
RICCI PAULDirectorJun 24, 2019 Buy$17.0040,000680,00020,000Jun 24, 2019, 08:02 PM
LUDLUM KENDirectorJun 24, 2019 Buy$17.0070,0001,190,00070,000Jun 24, 2019, 08:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MYERS WOODROW A JRDirector03/01/202416,700
Chen RichardCHIEF MEDICAL OFFICER AND EVP01/29/2024721
Tachibana AaronCFO AND COO01/29/2024981
Chen RichardChief Medical Officer and EVP12/15/20236,921
Tachibana AaronCFO and COO12/15/20239,918
Moore Stephen MichaelGeneral Counsel12/15/20232,170
Moore Stephen MichaelGeneral Counsel11/16/20231,791
Tachibana AaronCFO and COO11/16/20231,398
Chen RichardChief Medical Officer and EVP11/16/2023978
Hall Christopher MPresident and CEO11/01/202319,027
Tachibana AaronCFO and COO07/31/20231,496
Chen RichardChief Medical Officer and EVP07/31/20231,096
Moore Stephen MichaelGeneral Counsel06/16/20233,124
Chen RichardChief Medical Officer and EVP06/16/20239,971
Tachibana AaronCFO and COO06/16/202314,291
Tachibana AaronCFO and COO05/17/20232,750
Moore Stephen MichaelGeneral Counsel05/17/20233,526
Chen RichardChief Medical Officer and EVP05/17/20231,923
Moore Stephen MichaelGeneral Counsel05/02/202311,684
Tachibana AaronCFO and COO03/17/202311,164
Chen RichardChief Medical Officer and EVP03/17/20233,719
Tachibana AaronChief Financial Officer01/31/20231,687
Chen RichardChief Medical Officer01/31/20231,236
Tachibana AaronChief Financial Officer12/20/20227,379
Chen RichardChief Medical Officer12/20/20223,360
Moore Stephen MichaelGeneral Counsel12/15/20224,825
Tachibana AaronChief Financial Officer12/15/202217,943
Chen RichardChief Medical Officer12/15/202217,943
West John StephenPresident and CEO12/14/202224,400
Tachibana AaronChief Financial Officer12/02/202211,336
Chen RichardChief Medical Officer12/02/20221,144
Chen RichardChief Medical Officer11/16/20223,509
Moore Stephen MichaelGeneral Counsel11/16/20225,542
Tachibana AaronChief Financial Officer11/16/20223,507
Chen RichardChief Medical Officer09/20/20225,502
Tachibana AaronChief Financial Officer09/20/202212,090
Chen RichardChief Medical Officer09/02/20221,399
Tachibana AaronChief Financial Officer09/02/202213,879
Chen RichardChief Medical Officer07/28/20222,471
Tachibana AaronChief Financial Officer07/28/20222,471
Chen RichardChief Medical Officer06/17/20225,149
Tachibana AaronChief Financial Officer06/17/202211,318
Moore Stephen MichaelGeneral Counsel06/15/20225,936
Chen RichardChief Medical Officer06/15/202222,090
Tachibana AaronChief Financial Officer06/15/202222,090
Tachibana AaronChief Financial Officer06/02/202215,031
Chen RichardChief Medical Officer06/02/20221,511
Tachibana AaronChief Financial Officer05/16/20226,250
West John StephenPresident and CEO05/16/202211,703
Moore Stephen MichaelGeneral Counsel05/16/20223,227
Chen RichardChief Medical Officer04/29/20227,416
Chen RichardChief Medical Officer05/16/20226,250
Moore Stephen MichaelGeneral Counsel05/02/202231,703
West John StephenPresident and CEO04/20/202282,912
West John StephenPresident and CEO04/13/2022118,551
West John StephenPresident and CEO03/17/202299,998
Tachibana AaronChief Financial Officer03/17/202230,061
Chen RichardChief Medical Officer03/17/202214,172
West John StephenPresident and CEO03/15/2022125,418
West John StephenPresident and CEO03/14/202239,019
West John StephenPresident and CEO03/15/2022509,170
West John StephenPresident and CEO03/14/2022172,829
West John StephenPresident and CEO03/11/202220,034
West John StephenPresident and CEO03/10/202260,530
West John StephenPresident and CEO03/11/202297,883
West John StephenPresident and CEO03/10/2022308,574
West John StephenPresident and CEO03/11/202297,883
West John StephenPresident and CEO03/10/2022308,574
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner03/03/202249,305
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner03/03/20222,565,738
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner03/02/2022487,930
Chen RichardChief Medical Officer03/02/20224,795
Tachibana AaronChief Financial Officer03/02/202245,922
Chen RichardChief Medical Officer01/28/20227,001
Tachibana AaronChief Financial Officer01/28/20227,001
West John StephenPresident and CEO01/19/2022710,178
West John StephenPresident and CEO01/18/2022416,227
Tachibana AaronChief Financial Officer12/17/202143,994
Chen RichardChief Medical Officer12/17/202120,006
West John StephenPresident and CEO12/17/202134,970
West John StephenPresident and CEO12/16/20211,305,337
Chen RichardChief Medical Officer12/02/20215,413
Tachibana AaronChief Financial Officer12/02/202154,057
West John StephenPresident and CEO11/30/20211,365,000
West John StephenPresident and CEO11/17/202140,010
Tachibana AaronChief Financial Officer11/17/202121,351
Chen RichardChief Medical Officer10/29/202111,859
Chen RichardChief Medical Officer11/17/202121,351
West John StephenPresident and CEO10/12/20211,933,000
Tachibana AaronChief Financial Officer09/17/202166,980
Chen RichardChief Scientific Officer09/17/202123,120
West John StephenPresident and CEO09/14/20212,169,158
Tachibana AaronChief Financial Officer09/02/202183,734
Chen RichardChief Scientific Officer09/02/20216,379
West John StephenPresident and CEO08/26/202134,000
West John StephenPresident and CEO08/19/202150,700
West John StephenPresident and CEO08/19/20211,936,983
Chen RichardChief Scientific Officer08/06/2021329,646
Chen RichardChief Scientific Officer08/06/202194,132
West John StephenPresident and CEO07/15/202133,000
West John StephenPresident and CEO07/08/202148,400
West John StephenPresident and CEO07/08/20212,479,400
West John StephenPresident and CEO06/08/202148,400
West John StephenPresident and CEO06/08/20212,467,272
Chen RichardChief Scientific Officer06/02/20216,277
Chen RichardChief Scientific Officer03/17/202130,205
Tachibana AaronChief Financial Officer03/17/202165,382
Tachibana AaronChief Financial Officer03/02/202198,517
Chen RichardChief Scientific Officer03/02/202111,247
Chen RichardChief Scientific Officer02/01/20215,906
Chen RichardChief Scientific Officer02/01/20211,546,993
Chen RichardChief Scientific Officer12/17/202039,534
Tachibana AaronChief Financial Officer12/17/202086,961
Chen RichardChief Scientific Officer12/01/202017,600
Chen RichardChief Scientific Officer12/02/20208,134
Chen RichardChief Scientific Officer12/01/20201,119,989
Tachibana AaronChief Financial Officer12/02/202081,226
Abingworth LLPFormer 10% Owner10/20/20203,609,243
Abingworth LLP10% Owner10/19/20205,472,345
Abingworth LLP10% Owner10/16/20202,513,736
Abingworth LLP10% Owner10/15/202097,384
Abingworth LLP10% Owner10/14/20202,218,529
Abingworth LLP10% Owner10/12/20203,361,088
Abingworth LLP10% Owner10/13/20202,468,264
Chen RichardChief Scientific Officer10/01/202016,479
Chen RichardChief Scientific Officer10/01/2020882,452
Chen RichardChief Scientific Officer09/17/202025,469
Tachibana AaronChief Financial Officer09/17/202056,009
Tachibana AaronChief Financial Officer09/02/202066,648
Chen RichardChief Scientific Officer09/02/20206,690
Abingworth LLP10% Owner08/18/202018,749,998
Chen RichardChief Scientific Officer08/14/2020644,392
LUDLUM KENDirector08/14/2020403,394
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner08/14/202024,999,991
Chen RichardChief Scientific Officer06/22/202013,421
Chen RichardChief Scientific Officer06/05/20203,900
Chen RichardChief Scientific Officer06/01/20203,812
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner06/02/20205,321,543
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner06/01/20201,009,805
Chen RichardChief Scientific Officer03/09/20207,840
Chen RichardChief Scientific Officer02/25/2020885,770
Chen RichardChief Scientific Officer03/02/20208,760
Chen RichardChief Scientific Officer02/25/2020885,770
LUDLUM KENDirector02/07/202015,835
Chen RichardChief Scientific Officer01/07/20205,280
Chen RichardChief Scientific Officer12/20/20195,280
West John StephenPresident and CEO11/22/201925,952
RICCI PAULDirector06/24/2019680,000
LUDLUM KENDirector06/24/20191,190,000
Load More Insider Transactions
FUNDS WITH A POSITION IN PERSONALIS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ARK INVESTMENT MANAGEMENT LLC6,671,5450.08%16.65%Growth
BLACKROCK INC.3,315,2680.00018%-0.44%Other
RENAISSANCE TECHNOLOGIES LLC840,8110.00273%52.19%Other
D. E. SHAW & CO., INC.465,2420.00085%20.42%Other
GEODE CAPITAL MANAGEMENT, LLC389,7090.00009%4.79%Other
BRUCE & CO., INC.300,0000.22%NewValue
CHANGE IN SHARES OUTSTANDING FOR PERSONALIS INC
STOCK BUYBACKS FOR PERSONALIS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
1.85%
1Q
12/31/2023
06/30/2023
4.04%
2Q
12/31/2023
03/31/2023
6.11%
3Q
12/31/2023
12/31/2022
7.20%
4Q
12/31/2023
09/30/2022
8.00%
5Q
12/31/2023
06/30/2022
8.67%
6Q
12/31/2023
03/31/2022
10.23%
7Q
12/31/2023
12/31/2021
10.68%
8Q
12/31/2023
09/30/2021
11.42%
9Q
12/31/2023
06/30/2021
12.82%
10Q
12/31/2023
03/31/2021
17.35%
11Q
12/31/2023
12/31/2020
27.29%
12Q
12/31/2023
09/30/2020
39.87%
13Q
12/31/2023
06/30/2020
56.30%
14Q
12/31/2023
03/31/2020
58.23%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
1.85%
1Q
06/30/2023
4.04%
2Q
03/31/2023
6.11%
3Q
12/31/2022
7.20%
4Q
09/30/2022
8.00%
5Q
06/30/2022
8.67%
6Q
03/31/2022
10.23%
7Q
12/31/2021
10.68%
8Q
09/30/2021
11.42%
9Q
06/30/2021
12.82%
10Q
03/31/2021
17.35%
11Q
12/31/2020
27.29%
12Q
09/30/2020
39.87%
13Q
06/30/2020
56.30%
14Q
03/31/2020
58.23%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PERSONALIS INC
LOADING...